Sana Biotechnology (SANA) Accounts Payables (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Accounts Payables data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 114.66% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 114.66% YoY), and the FY2025 full-year result was $1.7 million, down 67.97% from the prior year.
• Accounts Payables climbed to $2.1 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $9.9 million in Q3 2023 to a low of $989000.0 in Q1 2025.
• A 5-year average of $3.6 million and a median of $3.1 million in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables soared 161.14% in 2024 and sank 83.77% in 2025, its largest moves.
• Tracing SANA's Accounts Payables over 5 years: stood at $2.9 million in 2022, then jumped by 43.79% to $4.1 million in 2023, then climbed by 26.83% to $5.2 million in 2024, then tumbled by 67.97% to $1.7 million in 2025, then climbed by 27.2% to $2.1 million in 2026.
• Business Quant data shows SANA's Accounts Payables at $2.1 million in Q1 2026, $1.7 million in Q4 2025, and $1.9 million in Q3 2025.